Cancellation of state registration. Paralene® Extra

December 19, 2017
Trade names:
ICD-10:
VI.G40-G47.G43    Migraine
X.J00-J06.J06.9    Acute upper respiratory tract infection, unspecified
X.J10-J18.J10    Influenza caused by an identified influenza virus
XI.K00-K14.K08.8    Other specified changes in teeth and their supporting apparatus
XIII.M20-M25.M25.5    Pain in the joint
XIII.M70-M79.M79.1    Myalgia
XIII.M70-M79.M79.2    Neuralgia and neuritis, unspecified
XIV.N80-N98.N94.4    Primary dysmenorrhea
XIV.N80-N98.N94.5    Secondary dysmenorrhea
XVIII.R50-R69.R50    Fever of unknown origin
XVIII.R50-R69.R51    Headache
XVIII.R50-R69.R52.0    Acute pain
XVIII.R50-R69.R52.2    Another constant pain
Paralen Extra, analgesic, antipyretic, pain, pain treatment, toothache, fever, fever, headache

The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate LSR-005892 / 08 of 23.07.2008 issued by Zentiva, Czech Republic):

Paralene® Extra (trade name of the medicinal product)

- (international non-proprietary or grouping or chemical name)

coated tablets (dosage form, dosage)

Zentiva, Czech Republic U kabelovny 130, 102 37 Prague 10, Dolni Mecholupy, Czech Republic (name and address of the location of the manufacturer of the medicinal product)

on the basis of an application by the authorized legal entity of the Sanofi-aventis Group JSC to cancel the state registration of the medicinal product.